M4Q (R2) is a globally harmonized framework for structuring quality information in medicinal product registration ...

In a recent industry research report from Veeva, data managers and clinical research associates (CRAs) detailed the daily ...

A look at how efficiency, access, platformization, AI, non-traditional players, and regulatory recovery are expected to reshape clinical operations in 2026. Efficiency, redefined: Faster trials ...

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for ...

The market is ripe for growth driven by pharma outsourcing to CDMOs, emphasizing advanced drug products and integrated ...

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

Piezofluorochromism, the phenomenon of materials reversibly changing their fluorescent color when pressure is applied, is ...

Candidates participating in the debate include Steve Hilton, Tom Steyer, Eric Swalwell, Tony Thurmond, Antonio Villaraigosa, ...

The Trump administration has rolled back decades-old guidance recommending routine childhood vaccination against influenza and three other infectious diseases, saying their use should instead be ...

While providers aren’t required to follow OIG recommendations, a compliance program based on their guidance can spare ...

Candidates participating in the debate include Steve Hilton, Tom Steyer, Eric Swalwell, Tony Thurmond, Antonio Villaraigosa, ...

The OBBBA reclassified bronze and catastrophic Exchange plans as qualifying HDHPs, allowing them to be paired with a health savings account (HSA). The Notice expressly confirms that enrollment in an ...